About the Company
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $REGN News
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
U.S. drugmaker Regeneron Pharmaceuticals Inc missed Wall Street estimates for quarterly profit on Thursday, hurt by softer ...
Regeneron Pharmaceuticals Targets Quality Weight Loss In Latest Obesity Innovation
On Thursday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported first-quarter adjusted EPS of $9.55, down 5% Y/Y, missing ...
Regeneron Pharmaceuticals Inc REGN
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Buy Rating Affirmed: Regeneron’s Promising Pipeline and Potential for Surpassing Earnings Expectations
Barclays analyst Carter Gould has maintained their bullish stance on REGN stock, giving a Buy rating yesterday. Carter Gould has given his Buy ...
Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight
Warning! GuruFocus has detected 7 Warning Signs with REGN. Regeneron Pharmaceuticals Inc (NASDAQ:REGN), a leader in ...
Regeneron Pharmaceuticals Inc REGN
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Buy Rating Affirmed for Regeneron on Strong Product Performance and Promising Pipeline Developments
Begin your TipRanks Premium journey today. Regeneron (REGN) Company Description: Founded in 1988, Regeneron Pharmaceuticals, Inc. is a New York-based biotechnology company, which discovers, ...
Regeneron falls after Q1 miss; announces $3B share buybacks
Regeneron Pharmaceuticals (REGN) stock falls despite a $3B in share buyback program as the company missed forecasts with its ...
Loading the latest forecasts...